Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer

European Journal of Cancer

Volumn 36, Issue 2, 2000, Pages 242-248

  Jonsson, M ^a   Borg, A ^a   Nilbert, M ^a   Andersson, T ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

catenin; APC; Breast cancer

Indexed keywords

BETA CATENIN; MYC PROTEIN;

ADULT; ARTICLE; BREAST CANCER; COLON POLYPOSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; BETA CATENIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CELL COMMUNICATION; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; MUTATION; NEOPLASM PROTEINS; SWEDEN; TRANS-ACTIVATORS;

EID: 0033976526     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00276-2     Document Type: Article

References (31)

1. Peifer M. β-catenin as oncogene: the smoking gun. Science 1997, 275, 1752-1753.
2. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 1997, 275, 1787-1790.
3. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997,275, 1784-1787.
4. Miller JR, Moon RT. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev 1996, 10, 2527-2539.
5. PapkofT J. Regulation of complexed and free catenin pools by distinct mechanisms. J Biol Chem 1997, 272, 4536-4543.
6. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16, 3797-3804.
7. Polakis P. The adenomatous polyposis coli (APC) tumour suppressor. Biochim Biophys Ada 1997, 1332, F127-F147.
8. Rubinfeld B, Albert I, Porfiri E, Munemitsu S, Polakis P. Loss of β-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 1997, 57, 4624-4630.
9. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumour-suppressor protein. Proc Nail Acad Sei USA 1995, 92, 3046-3050.
10. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilisation of β-catenin by genetic defects in melanoma cell lines. Science 1997, 275, 1790-1792.
11. Behrens J, von Kries JP, Kühl M, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996, 382, 3638-3642.
12. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281, 1509-1512.
13. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. Frequent alterations in E-cadherin and a- and β-catenin expression in human breast cancer cell lines. Oncogene 1995, 11, 1319-1326.
14. Baldetorp B, Dalberg M, Holst U, Lindgren G. Statistical evaluations of cell kinetic data from DNA flow cytometry (FMC) by the EM algorithm. Cytometry 1989, 10, 695-705.
15. Hiddeman W, Schumann J, AndreefT M, et al. Convention of nomenclature for DNA cytometry. Cytometry 1984, 5, 445-446.
16. van Hengel J, Nollet F, Berx G, van Roy N, Speleman F, van Roy F. Assignment of the human β-catenin gene (CTNNB1) to 3p22sp21.3 by fluorescence in situ hybridisation. Cytogenet Cell Genet 1995, 70, 68-70.
17. Wolman SR, Lanfrancone L, Dalla-Favera R, Ripley S, Henderso AS. Oncogene mobility in a human leukemia line HL-60. Cancer Genet Cytogenet 1985, 17, 133-141.
18. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995, 14, 6107-6115.
19. Borg Å, Baldetorp B, Fernö M, Killander D, Olsson H, Sigurdsson H. ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogens 1991, 6, 137-143.
20. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J. Transformation by Wnt family proteins correlates with regulation of β-catenin. Cell Growth Differ 1997, 8, 1349-1358.
21. Ilyas M, Tomlinson IP. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 1996, 182, 128-137.
22. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87, 159-170.
23. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK 3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996, 272, 1023-1026.
24. Escot C, Theillet C, Lidereau R, et al. Genetic alteration of the c-myc proto-oncogene in human primary breast carcinomas. Proc Nat! Acad Sei USA 1986, 83, 4834-4838.
25. Berns EM, Klijn JG, van Staveren IL, Portengen H, Noordegraaf E, Foekens JA. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur J Cancer 1992, 28A, 697-700.
26. Tetsu O, McCormick F. β-catenin regulates expression of cyclin Dl in colon carcinoma cells. Nature 1999, 398, 422-426.
27. Hoschuetzky H, Aberle H, Kemler R. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 1994, 127, 1375-1380.
28. Takeda H, Nagafuchi A, Yonemura S, et al. V-src kinase shifts the cadherin-based cell adhesion from the strong to the weak state and β-catenin is not required for the shift. J Cell Biol 1995, 131, 1839-1847.
29. Behrens J, Vakaet L, Friis R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993, 120, 757-766.
30. Birchmeier C, Birchmeier W, Brand-Saberi B. Epitheliamesenchymal transitions in cancer progression. Acta Anat Basel 1996, 156,217-226.
31. Roelink H, Wagenaar E, Nusse R. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors. Oncogene 1992, 7, 487-492.